Compare Edwards Lifesciences Corporation Common Stock (EW) vs Huntington Ingalls Industries Inc (HII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Huntington Ingalls Industries Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Huntington Ingalls Industries Inc trades at $265 (market cap $10.27B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 4.8× Huntington Ingalls Industries Inc's market cap, and Huntington Ingalls Industries Inc pays a 2.12% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | HII | |
|---|---|---|
Market Cap | $49.44B | $10.27B |
Volume | 3,508,027 | 554,386 |
Sector | Health | Industrials |
52-Week High | $95.18 | $453.73 |
52-Week Low | $72.65 | $257.05 |
Enterprise Value | $45.90B | $13.19B |
Typical Hold Time | — | 28 Days |
Dividend Yield | — | 2.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HII trades at $260.67, down 1.17% on the day, amid a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $5.27 exceeding expectations. Recent news highlights contract wins, including a $5.1 billion aircraft carrier overhaul and expansion in unmanned systems, supporting a $57.3 billion backlog. Valuation ratios appear reasonable with a P/E of 15.53 and P/S of 0.78.
The outlook is supported by robust defense budgets and contract momentum, but risks include execution on large projects and market sentiment. Analysts are mixed with a 40.7% buy rating and a consensus price target of $363.67, suggesting significant upside potential from current levels if operational performance continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →
